logo
Loads, lungs, and lymphoproliferative disorders
Epstein–Barr virus-associated pneumonia in patients with post-transplant lymphoproliferative disease after hematopoietic stem cell transplantation
Prevention of recurrent hepatitis B virus infection after liver transplantation
Clinical and radiological features of invasive pulmonary aspergillosis in transplant recipients and neutropenic patients
Risk factors and prognosis of invasive fungal infections in allogeneic stem cell transplantation recipients
Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy
Incidence and morbidity of human metapneumovirus and other community-acquired respiratory viruses in lung transplant recipients
Expanded infectious diseases screening program for Hispanic transplant candidates
Acute cellular rejection and Epstein–Barr virus-related post-transplant lymphoproliferative disorder in a pediatric lung transplant with low viral load
Hashimoto's encephalopathy after interferon therapy for hepatitis C virus in adult liver transplant recipient accompanied by post-transplant lymphoproliferative disorder related to Epstein–Barr virus infection
Herpes simplex virus hepatitis after pediatric liver transplantation
Should intravesical Bacillus Calmette-Guérin be employed in transplant recipients with bladder carcinoma?
Programmed death-1 receptor and interleukin-10 in liver transplant recipients at high risk for late cytomegalovirus disease
Invasive filamentous fungal infections associated with renal transplant tourism